In a retrospective analysis sponsored by AtriCure, healthcare systems saved an average of $8,601 in total healthcare costs for lobectomy patients who received Cryo Nerve Block (ablation) for post-op pain management compared to those who did not. ​

Learn more about the device reducing hospital system costs and relieving post-op pain at: <a href="https://okt.to/auKl0L&quot; target="_blank">https://okt.to/auKl0L</a&gt;

We're excited to share the Isolator® Synergy™ EnCompass® Clamp has received regulatory approval in CE-marked countries in Europe!

The EnCompass clamp provides a simpler and faster approach to ablating the heart in open-chest procedures.

Read the full release to learn more:… <a href="https://t.co/gouR2Xny4E&quot; target="_blank">https://t.co/gouR2Xny4E</a&gt;

Over the past two years, the EnCompass Clamp has made a real impact in advancing treatment alongside cardiac surgery in the U.S. We're eager to bring this innovative therapy to patients &amp; physician partners in Europe, expanding our international line.

We're excited to share the Isolator® Synergy™ EnCompass® Clamp has received regulatory approval in CE-marked countries in Europe!

AtriCure’s portfolio of bipolar radiofrequency (RF) ablation devices have been used in over 575,000 cases, backed by continuous innovation, clinical science, and education. The EnCompass clamp is our latest RF device providing a simpler and faster approach to ablating the heart in open-chest procedure.

Read the full release to learn more: <a href="https://okt.to/Qntpc3&quot; target="_blank">https://okt.to/Qntpc3</a&gt;

What an enriching experience over the past few days with the discussions and insights from physicians globally. As <a href="https://twitter.com/hashtag/APHRS2024?src=hashtag_click&quot; target="_blank">#APHRS2024</a> comes to a close, the AtriCure Asia-Pacific team would like to thank you all for your engagement and collaboration. See you all next year at APHRS 2025!

What an enriching experience over the past few days with the discussions and insights from physicians globally. As <a href='https://www.linkedin.com/feed/hashtag/?keywords=APHRS2024&highlightedUp…; target='_blank'>#APHRS2024</a> comes to a close, the AtriCure Asia-Pacific team would like to thank you all for your engagement and collaboration. See you all next year at APHRS 2025! ​
<a href='https://www.linkedin.com/feed/hashtag/?keywords=APHRS2024&highlightedUp…; target='_blank'>#APHRS2024</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=HybridAFTherapy&highlig…; target='_blank'>#HybridAFTherapy</a>​

We’re proud to stand with the American Heart Association in the fight against heart disease. From community walks to educational events, we’re committed to making a difference. Together, we can inspire healthier hearts everywhere. <a href='https://www.linkedin.com/feed/hashtag/?keywords=AHA&highlightedUpdateUr…; target='_blank'>#AHA</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=WorldHeartDay&highlight…; target='_blank'>#WorldHeartDay</a>

Honored to hear Dr. Daniel Miller of <a href="https://twitter.com/WellstarHealth&quot; target="_blank">@WellstarHealth</a> present his findings on the economic benefit of <a href="https://twitter.com/cryoNB&quot; target="_blank">@cryoNB</a> therapy in lobectomy patients at the <a href="https://twitter.com/AATSHQ&quot; target="_blank">@AATSHQ</a> Thoracic Surgical Oncology Summit. It’s encouraging to see the strides we’re making in pain management!

Today at <a href='https://www.linkedin.com/feed/hashtag/?keywords=ITSOS2024&highlightedUp…; target='_blank'>#ITSOS2024</a>, Dr. Daniel Miller presented the cost benefits of Cryo Nerve Block (ablation) for post-op pain management during surgical lobectomy.​

In a retrospective analysis sponsored by AtriCure, Cryo Nerve Block patients demonstrated:​

- $5,221 lower index admission costs compared to non-cryo patients, driven by a lower hospital length of stay. ​

- Less opioids after 90 days (p=0.03), leading to an even larger healthcare cost savings of $8,601 compared to non-cryo patients at 6 months post-surgery.​

Read the full abstract at: <a href="https://okt.to/yB86R4&quot; target="_blank">https://okt.to/yB86R4</a&gt; ​

Live at <a href="https://twitter.com/hashtag/ITSOS2024?src=hashtag_click&quot; target="_blank">#ITSOS2024</a> Dr. Miller shared results from a retrospective analysis sponsored by AtriCure which demonstrated Cryo Nerve Block patients had $5,221 lower admission costs, reduced opioid use &amp; $8,601 in savings at 6 months post-lobectomy compared to non-cryo patients. ​

Read… <a href="https://t.co/W3ObqqLlcB&quot; target="_blank">https://t.co/W3ObqqLlcB</a&gt;